Recruiting studies: Anticoagulation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism
Phase N/A · 14 location(s) · University of Calgary · NCT05756244 Nafamostat Efficacy in Phase 3 Registrational CRRT Study
NA · 10 location(s) · Talphera, Inc · NCT06150742 Early Surgical Fixation of Low-Velocity Hip Fractures in Patients With Direct Oral Anticoagulation
Phase N/A · 1 location(s) · Medical University of Vienna · NCT05070169 Caprini Score in Venous Surgery: a Prospective Cohort Study
Phase N/A · 1 location(s) · Pirogov Russian National Research Medical University · NCT03041805 Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation
NA · 22 location(s) · Beijing Anzhen Hospital · NCT06871228 Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
NA · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT07399977 A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
Phase 3 · 64 location(s) · Takeda · NCT05156983 Phase I Study of MT1011 Injection in Healthy Subjects
Phase 1 · 1 location(s) · Shaanxi Micot Pharmaceutical Technology Co., Ltd. · NCT07024160 Antithrombotic Therapy After Coronary Artery Bypass Grafting Combined With Coronary Endarterectomy
Phase 4 · 1 location(s) · China National Center for Cardiovascular Diseases · NCT05782270 LAAO Versus NOAC in Patients with AF and PCI
NA · 1 location(s) · Xijing Hospital · NCT05353140 Treatment With Aspirin Alone Versus Aspirin in Combination With Fondaparinux Before Early Coronary Assessment in Patient
Phase 4 · 10 location(s) · University of Aarhus · NCT06710184 The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial
Phase 3 · 19 location(s) · Population Health Research Institute · NCT04284839 Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake
Phase 4 · 14 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06571149 Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)
Phase N/A · 10 location(s) · McMaster University · NCT06844227 Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)
NA · 1 location(s) · Clinique Pasteur · NCT03297281 Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation
NA · 1 location(s) · Guangdong Provincial People's Hospital · NCT07441382 The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Phase 3 · 93 location(s) · Johns Hopkins University · NCT05836987 Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.
NA · 33 location(s) · Jena University Hospital · NCT04298723 Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replac
Phase 4 · 16 location(s) · Joon Bum Kim · NCT04258488 Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Phase 2 · 70 location(s) · Regeneron Pharmaceuticals · NCT07175428 Adverse Drug Events in Patients on Oral Anticoagulation in the Emergency Department
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Besancon · NCT06692504 Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest rece
Phase 2 · 1 location(s) · IRCCS San Raffaele · NCT06792643 A Novel Strategy of ECMO Management Using Nafamostat for Regional Combined With Low Intensity Systematic Anticoagulation
NA · 1 location(s) · Beijing Chao Yang Hospital · NCT06676085 BivaLirudin versUS Heparin in Extracorporeal Membrane Oxygenation
Phase 2 · 1 location(s) · Sydney Local Health District · NCT05959252 Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06954610 Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation
EARLY_Phase 1 · 12 location(s) · China National Center for Cardiovascular Diseases · NCT06615596 Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
Phase 3 · 34 location(s) · Region Stockholm · NCT05679024 AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study)
Phase 4 · 1 location(s) · Yonsei University · NCT04432220 Efficacy and Safety of Citrate Anticoagulation in CRRT for Patients With Liver Failure/DysfuncTION, the CAUTION Trial! A
Phase N/A · 1 location(s) · University Hospital, Antwerp · NCT06908746 Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With Anticoagulation
NA · 1 location(s) · Cedars-Sinai Medical Center · NCT02318342

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.